Videra Health Partners with North South Consulting Group to Help Prevent Suicide-Related Deaths of Service Members

Orem, Utah – October 1, 2024 – Videra Health, a leading AI-driven, end-to-end clinical operations solution, has announced a partnership with North South Consulting Group (NSCG), to help prevent suicide-related deaths of service members. The announcement comes as suicide-related deaths among military service members have risen by 37% over the last 20 years.

Through the use of a mobile phone or computer, Videra Health’s groundbreaking technology uses AI and machine learning algorithms to analyze video data. The AI detects subtle changes in facial expressions, body movements, language, and speech patterns that could indicate the risk of mental health conditions and can proactively identify individuals at a higher risk of suicide. This real-time detection ability results in immediate mental health interventions for service members and can ultimately save lives.

“Our goal at Videra Health is to use AI not just as a tool, but as a force for good in supporting the mental health of those who risk their lives for our country,” says Videra Health CEO & Co-Founder Loren Larsen. “We’re honored to work alongside North South Consulting Group in this important mission, providing service members with access to early effective interventions that can prevent tragedy and promote long-term wellness.”

In August, representatives from NSCG and Videra Health spoke at the Kentucky State Capitol’s Interim Joint Committee on Veterans, Military Affairs & Public Protection to address the challenges and risks associated with suicide-related deaths of service members.

“North South Consulting Group is a Veteran-owned and -led business which is passionate about supporting servicemembers and their families,” said Krista Stevans, CEO and President of North South Consulting Group “We take every opportunity to fight military suicide through the services we provide to our clients. Our partnership with Videra Health is another avenue to help the military using enhanced data insights.“

Recent data suggests that the younger population of today’s military are more apt to engage with clinicians and therapists via mobile devices and platforms than they would in a face-to-face or clinical setting. The data emphasizes the importance of identifying those in need of care and affording them with appropriate resources when they need them the most.

About Videra Health™

Videra Health is a leading AI-driven patient engagement and health assessment platform that empowers providers and healthcare organizations to proactively identify, triage, and monitor patients, closing care gaps using linguistic, audio and video analysis at scale. The FDA-registered digital platform transforms how doctors and healthcare systems interact and track a patient’s journey, illuminating the hidden depths of patient behavior and outcomes. Videra Health connects providers and patients anytime, anywhere, between visits and post-discharge via written and video assessments that translate into actionable quantitative and qualitative patient data. The platform streamlines diagnoses, enhances care accessibility, optimizes workflows and drives down costs for providers and healthcare systems. For more information, visit www.viderahealth.com.

###

Media Contact:
Videra Health
Stacy Callahan
stacy@astonishmediagroup.com

Videra Health Forms Advisory Board to Guide Continued Growth and Impact as a Leader in AI-driven Patient Engagement

Orem, Utah – July 31, 2024 – Videra Health™, a leading AI-driven clinical patient health assessment platform that empowers providers and healthcare organizations to proactively identify, triage, and monitor at-risk patients and close care gaps using linguistic, audio and video analysis, announced today the formation of its esteemed Advisory Board.

“This distinguished group of top leaders brings a wealth of experience across healthcare technology, mental health, and business strategy to guide Videra Health’s continued growth and impact,” says Loren Larsen CEO of Videra Health. “Their insights will be crucial as we continue to innovate and empower care providers to ‘see’ their patients beyond traditional methods, ultimately improving mental health outcomes and expanding access to care.”

Already recognized by customers as the top mental health screening platform, the newly formed advisory board will be instrumental in guiding the company as it expands and continues to drive growth. Each member of the advisory board brings a wealth of experience that will be key to Videra Health as the company continues to set the industry standard in the mental health market.

Videra Health’s Advisory Board Members Include:

  • Amir Lahav, a Digital Health Advisor and a leading innovator at the forefront of clinical research. With more than 20 years of clinical experience, Amir is on a mission to bring together the brightest minds from far-ranging disciplines to push the boundaries of AI-driven solutions in clinical research and medicine.
  • Chris Klomp, the former CEO of Collective Medical with a proven track record of building and scaling across healthtech. Chris was previously with Bain & Co and Bain Capital for many years. He is currently a board director and advisor to multiple healthcare organizations including Nomi Health, Maven Clinic, and InnovaCare Health, and is a commissioner of the Utah Digital Health Services Commission.
  • Owen Scott Muir, M.D., DFAACAP,  a dual board Certified child and general psychiatrist and distinguished fellow of the American Academy of Child and adolescent psychiatry.  Dr. Muir is an international speaker, Chief medical officer of iRxReminder, Fermata, and SVP, at Acacia Clinics, and a prolific best-selling author of both popular press and scientific work focusing on AI diagnostics and treatment resistant conditions.
  • Wylie van den Akker, a seasoned software engineer with expertise in machine learning and data security. Wylie co-founded Collective Medical and served as VP of Innovation at PointClickCare. He brings a unique blend of technical and business acumen to Videra Health, optimizing the technology platform and helping with technical integrations.

“AI is already impacting healthcare, and Videra is on the bleeding edge of how we can use this technology to more safely, proactively, scalably, and inexpensively improve both patient care and the provider experience,” shared Chris Klomp, advisor to Videra. “Videra stands out not only for their innovative use of AI in health detection–utilizing deep data insights to deliver tailored and seamless care experiences to patients and the providers who serve them–but in how they do so by putting patient safety and privacy at the forefront of their efforts. I am deeply passionate about this area and excited to contribute to Videra Health’s mission.”

The formation of the advisory board underscores the company’s commitment to continuous innovation and excellence. With the guidance of these distinguished leaders, Videra Health is poised to set new standards in mental health care, ensuring that more patients receive the critical support they need and deserve.

About Videra Health™

Videra Health is a leading AI-driven patient engagement and health assessment platform that empowers providers and healthcare organizations to proactively identify, triage, and monitor patients, closing care gaps using linguistic, audio and video analysis at scale. The FDA-registered digital platform transforms how doctors and healthcare systems interact and track a patient’s journey, illuminating the hidden depths of patient behavior and outcomes. Videra Health connects providers and patients anytime, anywhere, between visits and post-discharge via written and video assessments that translate into actionable quantitative and qualitative patient data. The platform streamlines diagnoses, enhances care accessibility, optimizes workflows and drives down costs for providers and healthcare systems. For more information, visit www.viderahealth.com.

###

Media Contact:
Videra Health
Stacy Callahan
stacy@astonishmediagroup.com

RamaOnHealthcare Q&A: Brett Talbot, CCO and Loren Larsen, CEO of Videra Health

Discover how Videra Health is transforming mental health care in this insightful Q&A with Loren Larsen, CEO, and Brett Talbot, Chief Clinical Officer. They explore the innovative use of AI and video technology in mental health assessments, highlighting the benefits of enhanced accuracy and accessibility. They also delve into how AI has the potential to benefit PTSD specifically. Learn about the challenges and breakthroughs shaping the future of mental health care. Read the full article here.

The Future of TD Screening is Here: AI Takes on Tardive Dyskinesia Detection

May 5-11, 2024 is Tardive Dyskinesia (TD) Awareness Week. This annual campaign is meant to raise awareness and understanding of TD, a neurological disorder that can result from long-term use of certain medications for mental health conditions. As an AI technology company committed to improving healthcare, we are excited to announce our latest innovation – TDScreen, an AI video screener for estimating risk of TD.

The Importance of Tardive Dyskinesia Awareness Week

Tardive Dyskinesia is a condition that causes involuntary and repetitive movements, such as lip smacking, tongue protrusion, and jaw movements. It can have a significant impact on the quality of life of those affected, causing embarrassment and social isolation. Yet, many people, including healthcare providers, are still unfamiliar with TD. This is why TD Awareness Week is crucial in bringing attention to this condition and promoting early detection and treatment.

The Need for Proactive Tardive Dyskinesia Identification

Traditionally, TD is diagnosed through a lengthy physical examination conducted by a healthcare provider using the Abnormal Involuntary Movement Scale (AIMS) that requires extensive training. However, this can be challenging for patients who are unable to visit a clinic regularly. As a result, TD may go undetected and untreated, leading to irreversible symptoms and further deterioration of overall health. This is where TDScreen comes in – providing a proactive and convenient solution for remotely estimating risk of TD.  When TD is identified early there are two FDA approved medications, valbenazine (Ingrezza®) and deutetrabenazine (Austedo®).

Introducing TDScreen: An AI Video Assessment

TDScreen harnesses the power of artificial intelligence to analyze video footage of patients for potential signs of TD. Through advanced algorithms, TDScreen is able to detect subtle and early signs of TD, even those that may go unnoticed by the human eye. This means that patients can be screened for TD from the comfort of their own home, without the need for in-person appointments.

How TDScreen Works

TDScreen is easy to use and requires no special equipment. All patients need is a smartphone, tablet, or laptop with a front-facing camera. The screening takes less than 5 minutes to complete and can be done in the comfort of their own home. Patients simply record themselves performing a series of movements and facial expressions while following instructions on the screen. The video is then securely uploaded to our platform for analysis.

The Benefits of TDScreen for Providers and Patients

For providers, TDScreen offers a way to stay ahead of TD, even with patients who are unable to visit the clinic regularly. By being proactive in identifying TD, providers can work towards early intervention and better outcomes for their patients. For patients, TDScreen provides a convenient and non-invasive way to get screened for TD without the need for frequent in-person appointments. It also offers peace of mind, knowing that they are being regularly monitored for potential signs of TD.

How Providers Can Use TDScreen During Tardive Dyskinesia Awareness Week

We encourage all providers, especially neurologists and psychiatrists, to take advantage of Tardive Dyskinesia Awareness Week and introduce TDScreen to their patients as a proactive tool for TD detection. We provide providers with a special identification code to share with their patients, allowing them to easily complete the TDScreen assessment and have their results automatically shared with the requesting provider.

TDScreen: Changing the Game in Remote Tardive Dyskinesia Screening

At our core, we are driven by our mission to improve healthcare outcomes through the use of innovative technologies like TDScreen. This TD Awareness Week, we are proud to offer an efficient and effective solution for remote TD risk detection, making it easier for providers to identify TD early and ultimately improve the lives of their patients. Join us in raising awareness for TD and taking a proactive approach to TD detection with TDScreen.

Recognizing support from iRx Reminder and NIMH funding (Grant No. 2R44MH114763).